Filing Details

Accession Number:
0001179110-14-015987
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-03 17:14:49
Reporting Period:
2014-10-31
Filing Date:
2014-11-03
Accepted Time:
2014-11-03 17:14:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203350 S Ronald Poelman 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-31 4,491 $28.16 4,491 No 4 M Direct
Common Stock Disposition 2014-10-31 4,491 $112.53 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2014-10-31 6,000 $0.00 6,000 $28.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,000 2013-07-01 2015-09-30 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
  2. Weighted average price. Price range in multiple transactions was $112.00 to $113.04, inclusive.